LASILIX 20 mg/2 ml, solution for injection in an ampoule ampoule, 2 ml
Active ingredients: Furosemide
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionampoule, 2 mlintramusculaire;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LASILIX 20 mg/2 ml, solution injectable en ampoule
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 1 ampoule(s) en verre de 2 ml
- Marketing authorisation holder
- SANOFI WINTHROP INDUSTRIE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Oct 1965
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66441419CIP73057331CIP133400930573310Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FUROSÉMIDEsolution | 20 mg · une ampoule de 2 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.